793
Views
24
CrossRef citations to date
0
Altmetric
Article Addendum

The expression of SPARC in human tumors is consistent with its role during cell competition

, &
Pages 171-174 | Received 17 Nov 2010, Accepted 17 Nov 2010, Published online: 01 Mar 2011

References

  • Moreno E. Is cell competition relevant to cancer?. Nat Rev Cancer 2008; 8:141 - 147
  • Morata G, Ripoll P. Minutes: mutants of drosophila autonomously affecting cell division rate. Dev Biol 1975; 42:211 - 221
  • Moreno E, Basler K, Morata G. Cells compete for decapentaplegic survival factor to prevent apoptosis in Drosophila wing development. Nature 2002; 416:755 - 759
  • Rhiner C, Lopez-Gay JM, Soldini D, Casas-Tintó S, Martín FA, Moreno E. Flower forms an extracellular code that reveals the fitness of a cell to its neighbors in Drosophila. Dev Cell 2010; 18:882 - 883
  • Moreno E. A war-prone tribe migrated out of Africa to populate the world. Nature 2010; Available at http://hdl.handle.net/10101/npre.2010.4303.1
  • Hassig R. Aztec Warfare: Imperial Expansion and Political Control. Civilization of the American Indian series, no. 188 1988; Norman, OK University of Oklahoma
  • Moreno E, Basler K. dMyc transforms cells into super-competitors. Cell 2004; 117:117 - 129
  • Rhiner C, Moreno E. Super competition as a possible mechanism to pioneer precancerous fields. Carcinogenesis 2009; 30:723 - 728
  • Portela M, Casas-Tinto S, Rhiner C, López-Gay JM, Domínguez O, Soldini D, et al. Drosophila SPARC is a self-protective signal expressed by loser cells during cell competition. Dev Cell 2010; 19:562 - 573
  • Clark CJ, Sage EH. A prototypic matricellular protein in the tumor microenvironment—where there's SPARC, there's fire. J Cell Biochem 2008; 104:721 - 732
  • Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, et al. Genes that mediate breast cancer metastasis to lung. Nature 2005; 436:518 - 524
  • Mantoni TS, Schendel RR, Rodel F, Niedobitek G, Al-Assar O, Masamune A, et al. Stromal SPARC expression and patient survival after chemoradiation for non-resectable pancreatic adenocarcinoma. Cancer Biol Ther 2008; 7:1806 - 1815
  • Best CJ, Gillespie JW, Yi Y, Chandramouli GV, Perlmutter MA, Gathright Y, et al. olecular alterations in primary prostate cancer after androgen ablation therapy. Clin Cancer Res 2005; 11:6823 - 6834
  • Lapointe J, Li C, Higgins JP, van de Rijn M, Bair E, Montgomery K, et al. Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci USA 2004; 101:811 - 816